Form 4: CME Group Director Daniel Glickman Reports Acquisition of Shares

Director Daniel Glickman reports acquiring 748 shares of CME Group Inc. at $194.10 per share on June 25, 2024, and holds 14,756 shares directly and 2,100 indirectly through a trust.

Summary

• On June 25, 2024, Daniel Glickman, a director of CME Group Inc., acquired 748 shares of Common Stock Class A at a price of $194.10 per share.
• This acquisition was made pursuant to the CME Group Director Stock Plan, as amended and restated.
• Following the transaction, Glickman directly owns 14,756 shares of Common Stock Class A.
• Glickman also indirectly owns 2,100 shares through a trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it's a standard regulatory filing reporting a director's stock acquisition. It doesn't inherently indicate positive or negative sentiment, but rather provides factual information.

Positives

• The director's acquisition of shares may signal confidence in the company's future performance.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to the market.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider activity.

Key Dates